Joana del Valle Mercado Hernández

Dr. Joana del Valle Mercado Hernández

Instituto de Investigación Biomédica de Salamanca, Salamanca, Castille-Leon, Spain
+1
orcid

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
Verified
Journal Article
Open access
PDF file
SSSandra Sancho
Sandra Sancho
MHMaría Herrero
María Herrero
Miguel Fontecha-BarriusoMiguel Fontecha-Barriuso
Miguel Fontecha-Barriuso
Joana del Valle Mercado HernándezJoana del Valle Mercado Hernández
Joana del Valle Mercado Hernández
FLFrancisco J. López-Hernández
Francisco J. López-Hernández
Nephrotoxicity is a major cause of intrinsic acute kidney injury (AKI). Because renal tissue damage may occur independently of a reduction in glomerular filtration rate and of elevations in plasma creatinine concentration, so-called injury biomarkers have been proposed to form part of diagnostic criteria as reflective of tubular damage independently of renal function status. We studied whether the urinary level of NGAL, KIM-1, GM2AP, t-gelsolin, and REGIIIb informed on the extent of tubular damage in rat models of nephrotoxicity, regardless of the etiology, moment of observation, and underlying pathophysiology. At a time of overt AKI, urinary biomarkers were measured by Western blot or ELISA, and tubular necrosis was scored from histological specimens stained with hematoxylin and eosin. Correlation and regression studies revealed that only weak relations existed between biomarkers and tubular damage. Due to high interindividual variability in the extent of damage for any given biomarker level, urinary injury biomarkers did not necessarily reflect the extent of the underlying tissue injury in individual rats. We contended, in this work, that further pathophysiological contextualization is necessary to understand the diagnostic significance of injury biomarkers before they can be used for renal tubular damage severity stratification in the context of nephrotoxic and, in general, intrinsic AKI.

Verified
Journal Article
Open access
PDF file
GMGiampiero Andrea Massaro
Giampiero Andrea Massaro
Joana del Valle Mercado HernándezJoana del Valle Mercado Hernández
Joana del Valle Mercado Hernández
RBRoel Broekhuizen
Roel Broekhuizen
TNTri Nguyen
Tri Nguyen
IFIsabel Fuentes-Calvo
Isabel Fuentes-Calvo
FLFrancisco J. López-Hernández
Francisco J. López-Hernández
Chronic kidney disease (CKD) poses a global burden affecting over 10% of the adult population worldwide. Acute kidney injury (AKI) is an important cause of CKD, especially following severe and repeated episodes. However, the processes underpinning progressive and chronic renal deterioration after AKI are only incompletely understood. Thus, models reproducing this scenario are needed to study the pathophysiological mechanisms involved and identify biomarkers and molecular targets for diagnostic and therapeutic purposes. In this study, we developed a rat model of 3 serial AKIs leading to CKD, in which renal function, kidney structure and fibrosis, and urinary injury biomarkers were studied over a period of 9 months, alongside a traditional model of CKD caused by renal mass reduction. Our results show that consecutive AKIs eventually develop key features of CKD including progressive fibrosis and albuminuria. Renal injury biomarkers neutrophil gelatinase-associated lipocalin (NGAL), kidney injury molecule 1 (KIM-1), and retinol binding protein 4 (RBP4) show distinct evolution patterns suggestive of specific but undetermined damages with different time courses. The chronic evolution of renal tissue degeneration and dysfunction following serial AKIs closely resembles those observed after extensive renal mass reduction, which indicates chronic degeneration. Finally, a clear dissociation in the evolution of interstitial fibrosis (progressively increasing) and of glomerular filtration (mainly stable) was observed in both models. This questions the consuetudinary paradigm ascribing an etiological role to fibrosis in progressive renal dysfunction.

29 September 2026 in BioMedInformatics
Verified
Journal Article
Open access
PDF file
Joana del Valle Mercado HernándezJoana del Valle Mercado Hernández
Joana del Valle Mercado Hernández
DMDavid Martín-Calvo
David Martín-Calvo
GCGiada Carniglia
Giada Carniglia
NMNoelia Díaz Morales
Noelia Díaz Morales
ADAnnette Düwel
Annette Düwel
CMCarlos Martinez-Salgado
Carlos Martinez-Salgado
(1) Background: Simultaneous evaluation of acute and chronic lesions is critical for staging renal disease, yet manual assessment suffers from high inter-observer variability and heavy workloads. While deep learning models excel at structural segmentation, none currently consolidate the concurrent quantification of key AKI-to-CKD transition markers on standard-stained tissue slides. (2) Methods: We developed a U-Net-based convolutional neural network for the pixel-wise segmentation and quantification of inflammation-associated interstitial fibrosis and tubular atrophy (i-IFTA), focal inflammatory infiltrates and tubular dilation in haematoxylin–eosin-stained whole-slide images (WSIs) from rat models of renal injury. (3) Results: The model demonstrated robust pixel-wise segmentation in H&E-stained rodent renal tissue (overall accuracy: 88.26%, macro-averaged Dice coefficient: 0.843; per-class Dice ranging from 0.727 for focal infiltrates to 0.920 for unaltered tissue). While comparative evaluation against human annotators was performed on a limited patch subset, the model exhibited agreement trends close to expert pathologists and superior to junior annotators. The end-to-end WSI inference pipeline generates full-slide visual overlays and automated WSI-level quantitative area measurements in a mean time of 103.57 s per WSI on GPU hardware. (4) Conclusions: This model offers an objective and automated framework for quantifying key structural and inflammatory lesions in rodent renal tissue. By enabling rapid WSI-level quantitative area measurements, it establishes a solid foundation for preclinical histopathological assessment and provides high potential for future translation into human clinical pathology.

2 December 2025 in bioRxiv
Verified
Preprint
Open access
Joana del Valle Mercado HernándezJoana del Valle Mercado Hernández
Joana del Valle Mercado Hernández
IFIsabel Fuentes-Calvo
Isabel Fuentes-Calvo
DMDavid Martín-Calvo
David Martín-Calvo
SSSandra Sancho
Sandra Sancho
FLFrancisco J. López-Hernández
Francisco J. López-Hernández
CMCarlos Martinez-Salgado
Carlos Martinez-Salgado
Defective renal repair following acute kidney injury (AKI) may lead to acute kidney disease (AKD), defined by persistent functional and/or structural abnormalities lasting up to three months. However, subclinical AKD often goes undetected due to the lack of specific diagnostic tools, as conventional biomarkers such as plasma creatinine (pCr) may remain within normal limits despite underlying structural damage. To identify urinary proteomic signatures associated with subclinical AKD of differing etiologies, we induced AKI in Wistar rats using either toxic (cisplatin-induced) or ischemic (unilateral ischaemia-reperfusion, I/R) models, and monitored renal function, renal histopathology and urine composition over 42 days. Renal function, as assessed by pCr and creatinine clearance, was rapidly and severely impaired following treatment with cisplatin and I/R, and normalized afterwards within 10 and 2 days, respectively. Despite functional recovery, histological analysis revealed persistent tissue injury—characterized by tubular dilation, necrosis, inflammation, and interstitial fibrosis—particularly in cisplatin-treated animals at day 42. Urinary proteomic analysis identified 53 and 23 proteins that were differentially excreted with the urine in the cisplatin and I/R groups, respectively, compared to controls, and 11 proteins differed from one AKI etiology to the other. Additionally, 29 proteins appeared exclusively post-AKI, irrespective of cause. Most of these proteins are predominantly involved in the immune response, complement activation, haemostasis, and gluconeogenesis. These findings suggest that urinary proteomic fingerprints may serve as sensitive indicators of subclinical AKD, reflecting underlying structural damage even in the absence of overt functional impairment. Such profiles could offer etiology-specific insights, while also enabling the early detection of AKD across diverse injury contexts.

13 July 2026 in Preprints.org
Verified
Preprint
Open access
PDF file
Joana del Valle Mercado HernándezJoana del Valle Mercado Hernández
Joana del Valle Mercado Hernández
DMDavid Martín-Calvo
David Martín-Calvo
GCGiada Carniglia
Giada Carniglia
NMNoelia Díaz Morales
Noelia Díaz Morales
ADAnnette Düwel
Annette Düwel
CMCarlos Martinez-Salgado
Carlos Martinez-Salgado
Simultaneous evaluation of acute and chronic lesions is critical for staging renal disease, yet manual assessment suffers from high inter-observer variability and heavy workloads. While deep learning models excel at structural segmentation, none currently consolidate the concurrent quantification of key AKI-to-CKD transition markers in standard stains. We developed a modified U-Net convolutional neural network for the pixel-wise segmentation and quantification of inflammation-associated interstitial fibrosis and tubular atrophy (i-IFTA), focal inflammatory infiltrates and tubular dilation in haematoxylin-eosin-stained whole-slide images (WSIs) from rat models of renal injury. The model achieved an overall test accuracy of 90.21% (weighted F1-score: 90.22%). Per-class F1-scores ranged from 0.73 for focal infiltrates to 0.94 for unaltered tissue, mirroring biological class distributions. Expert pathologists validated the high quality of the boundaries, which was comparable to junior-level annotations. The end-to-end inference pipeline successfully generates full-slide visual overlays and automated quantitative area metrics in a mean time of 215 seconds per WSI on standard CPU hardware. This model addresses a critical gap by simultaneously quantifying key structural and inflammatory lesions in H&E tissue. By reducing evaluation times from hours to minutes, it offers a scalable, reproducible tool to standardize histopathological assessment.